Clear Street Markets LLC Gilead Sciences, Inc. Call Options Transaction History

Clear Street Markets LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $98,464 - $123,386	-1,700 Reduced 28.33%	4,300 $256,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $386,036 - $438,158	5,950 Added 11900.0%	6,000 $436,000
Q2 2021 Jul 19, 2021	SELL	$63.47 - $69.35 $19,041 - $20,805	-300 Reduced 85.71%	50 $344,000
Q4 2020 Feb 25, 2021	SELL	$56.65 - $64.55 $15,862 - $18,074	-280 Reduced 44.44%	350 $20,000
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $4,347 - $5,465	-70 Reduced 10.0%	630 $3.98 Million
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $38,642 - $49,495	617 Added 743.37%	700 $5.23 Million
Q4 2019 Jan 13, 2020	SELL	$61.62 - $67.78 $2,834 - $3,117	-46 Reduced 35.66%	83 $539,000
Q4 2018 Jan 23, 2019	BUY	$60.54 - $79.0 $2,482 - $3,239	41 Added 46.59%	129 $807,000
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $6,345 - $7,521	88	88 $713,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.